S. SOVERINI Et Al. , "Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study," 55.th ASH Meeting 2013 , vol.122, 2013
SOVERINI, S. Et Al. 2013. Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study. 55.th ASH Meeting 2013 .
SOVERINI, S., ERNST, T., KOHLMANN, A., DE BENEDITTIS, C., ALIKIAN, M., FORONI, L., ... POLOVAKA, K.(2013). Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study . 55.th ASH Meeting 2013
SOVERINI, SIMONA Et Al. "Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study," 55.th ASH Meeting 2013, 2013
SOVERINI, SIMONA Et Al. "Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study." 55.th ASH Meeting 2013 , 2013
SOVERINI, S. Et Al. (2013) . "Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study." 55.th ASH Meeting 2013 .
@conferencepaper{conferencepaper, author={SIMONA SOVERINI Et Al. }, title={Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study}, congress name={55.th ASH Meeting 2013}, city={}, country={}, year={2013}}